Follow Us TR

News Details

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal

About Kazia Therapeutics Limited
  • NASDAQ: $KZIA
  • Notified: $3.18
  • 10:31 EDT

Price Chart